CLO20-069: Evaluation and analysis of postoperative complications after primary cytoreduction for 47 cases of advanced epithelial ovarian cancer at stage IIIc and IV RUNNING HEAD (maximum 40 characters): Complications after primary cytoreduction in ovarian cancer
Ying Zhou(Jiangmen Central Hospital), Björn Nashan(Medizinische Hochschule Hannover), Hanhui Yao, Rongzhu Chen, Jing Zhu, Wei Wei(Zhujiang Hospital), Tianjiao Zhang(University of Science and Technology of China), Yanhu Xie(University of Science and Technology of China), Min Li(Sun Yat-sen University), Zhen Shen(University of Science and Technology of China), Chenchen Zhu(Stanford University), Shuai Yin(First Affiliated Hospital of Henan University of Traditional Chinese Medicine), Dabao Wu, Jiwei Qin, Wei Zhang(Central South University), Guihong Wang(Capital Medical University), Zheng Zhou
Cited by 0
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
|Journal of the American Society of Nephrology|2002|274
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study
|The Lancet|2001|256
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation
|Journal of Clinical Oncology|1999|216